ArticleJournal of the American Board of Family Medicine : JABFM2026
Is the Availability of Immediate Inpatient Postpartum Long-Acting Reversible Contraception (LARC) Associated with a Decrease in Rapid Repeat Pregnancy?
Article in Journal of the American Board of Family Medicine : JABFM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Women's Health, Social Issues, and Quality of Care in Family Medicine.Journal of the American Board of Family Medicine : JABFMArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionImmediate postpartum long-acting reversible contraception (IPP-LARC) after delivery may decrease rapid repeat pregnancy (RRP). RRP is associated with preterm birth, small for gestational age, low birth weight, and infant/maternal mortality. In April 2017, the Ohio legislature passed SB 332, mandating immediate postpartum LARC coverage. Later that year, our hospital made the IPP-LARC Nexplanon (and not intrauterine devices [IUDs]) available to all delivering patients. This study aimed to see if SB 332 is associated with decreased RRP.
methodsUsing electronic health record and state registry data, we examined sociodemographic and perinatal care variables for 726 pregnant adolescents and adults delivering at our hospital during the 12 months before and after IPP-LARC became available. We then determined the association between RRP and these variables.
resultsAfter LARC became available, 62/368 patients chose Nexplanon. Gravidity (OR: 1.128) and vaginal delivery (OR: 1.682) were negatively associated with RRP while age at delivery was inversely associated (OR: 0.902,
conclusionsAfter SB 332's passage, IPP-LARC availability was positively associated with RRP, but the percentage of patients who chose IPP-LARC was low. However, RRP occurred less often among patients who chose IPP-LARC placement. Hospital systems must actively invest in patient education and provider support to ensure interventions to reduce rapid repeat pregnancy are optimally utilized by vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.